Navigation Links
Oramed Pharmaceuticals Announces Withdrawal of Proposed Underwritten Public Offering
Date:6/21/2013

s, or when we discuss our clinical trials. These forward-looking statements are based on the current expectations of the management of Oramed only, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements, including the risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval or patent protection for our product candidates; competition from other pharmaceutical or biotechnology companies; and our ability to obtain additional funding required to conduct our research, development and commercialization activities. In addition, the following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: changes in technology and market requirements; delays or obstacles in launching our clinical trials; changes in legislation; inability to timely develop and introduce new technologies, products and applications; lack of validation of our technology as we progress further and lack of acceptance of our methods by the scientific community; inability to retain or attract key employees whose knowledge is essential to the development of our products; unforeseen scientific difficulties that may develop with our process; greater cost of final product than anticipated; loss of market share and pressure on pricing resulting from competition; laboratory results that do not translate to equally good results in real settings; our patents may not be sufficient; and final that products may harm recipients, all of which could cause the actual results or performance of Oramed to differ materially from those contemplated in such forward-looking statements. Except as otherwise required by law, Oramed undertakes no obligation to publicly release any revisions to these forward-looking statements to
'/>"/>
SOURCE Oramed Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Oramed Pharmaceuticals to Present at IATI-BioMed Conference in Israel
2. Oramed Selected to Present at the 81st European Atherosclerosis Society Congress in Lyon, France, June 2-5, 2013
3. Oramed Pharmaceuticals Awarded Grant by the Office of the Chief Scientist of Israel
4. Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S.
5. Clinical Results for Orameds Oral Diabetes Treatment Published in Peer Reviewed Journal PLOS ONE
6. Oramed Pharmaceuticals to Present Results of its Key Clinical Studies of Oral Insulin in Type 1 Diabetes Patients at the GTC Diabetes Summit, Boston, MA; April 29-30, 2013
7. Oramed Pharmaceuticals Chosen to Present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria; April 18-20, 2013
8. Oramed Pharmaceuticals Appoints New Chief Operating Officer and VP of Business Development
9. Oramed Submits New IND Application for Oral Insulin Trial in the US
10. Oramed Pharmaceuticals Granted Japanese Patent for its Core Technology in Oral Delivery of Proteins
11. Oramed Pharmaceuticals to Present at the 4th Annual Drug Delivery & Formulation Summit in Berlin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... NEWTON, Mass. and JERUSALEM ... privately-held biopharma company developing octreotide capsules, its lead product ... of a $70 million Series E financing round. Participants ... and Sofinnova Ventures, and an undisclosed blue chip public ... F2 Capital, 7 Med Health Ventures, Abingworth and ARCH ...
(Date:2/26/2015)... , Feb. 27, 2015  Finesse expands office in ... Solutions announced the expansion of its operations in ... for mid-March and access for customers is expected shortly ... and located adjacent to the current office, the new ... engineering team and allow Finesse to bring on more ...
(Date:2/26/2015)... , Feb. 26, 2015  Tandem Diabetes Care®, ... company and manufacturer of the t:slim® and t:flex™ Insulin ... offering of 5,250,000 shares of its common stock at ... The net proceeds to Tandem from this offering are ... and commissions and other estimated offering expenses payable by ...
Breaking Medicine Technology:Chiasma Announces Completion of $70 Million Series E Financing 2Chiasma Announces Completion of $70 Million Series E Financing 3New Finesse Office in United Kingdom 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3
... published in the American Journal of Nephrology -, ... announced that its Phase III data on VAPRISOL was ... Nephrology. In this study,VAPRISOL showed a significant increase in ... life-threatening condition that,occurs when the body,s sodium level falls ...
... Cancer patients at Beaumont,Hospitals are the first in the ... therapy that is painless, faster, more accurate and precise,than ... patented the new,technology, Omnibeam(R). The $3.3-million machine is manufactured ... first patient,was treated on Sept. 10. The painless ...
Cached Medicine Technology:Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 2Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 3Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 4Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 5Beaumont Patients 1st to get Next Generation of Radiation Treatment 2
(Date:2/27/2015)... February 27, 2015 Several studies showing ... heart failure have made headline news recently. However, all ... research appearing in this month’s STEM CELLS Translational Medicine ... in treating children with congenital heart diseases that can ... by researchers at the Mayo Clinic in Rochester, Minn., ...
(Date:2/27/2015)... Ticket Down announces that Ed Sheeran ... of 2015. Tickets for his tour have been a ... record pace. , Ed Sheeran 2015 Tour Dates: ... Wednesday, May 6, 2015 , 5/7/15, Ed Sheeran Tickets, Grand ... 2015 , 5/9/15, Ed Sheeran Tickets, Tulsa, OK BOK Center, ...
(Date:2/27/2015)... Burien Nursing and Rehabilitation Center was ... with the Facility of the Year award. This award ... quality of care / satisfaction, census development, employee satisfaction ... to attend the awards banquet held in Dana Point, ... receive this award on behalf of our team at ...
(Date:2/27/2015)... 2015 RDI-Engineering will be hosting an ... event on March 14, at Moreno Valley College. The ... how to use engineering software and tools, and a ... by Moreno Valley College’s Upward Bound Math and Science ... in hopes to encourage students to seek educational and ...
(Date:2/27/2015)... Vegas, NV (PRWEB) February 27, 2015 Leading ... bring health and wellness to Americans nationwide. Each month they ... aspects of health and wellness, and healthy living. In the ... Week. National Sleep Awareness Week starts by bringing ... Daylight Savings. This year Sleep Awareness Week will start on ...
Breaking Medicine News(10 mins):Health News:Study Shows Stem Cells Have Potential to Help Kids’ Hearts, Too 2Health News:Ed Sheeran Tickets at the Hollywood Bowl, Verizon Theatre, The Mann Center, Darlings Waterfront Pavilion, Moda Center, BOK Center, Consol Energy & Red Rocks Now On Sale 2Health News:Ed Sheeran Tickets at the Hollywood Bowl, Verizon Theatre, The Mann Center, Darlings Waterfront Pavilion, Moda Center, BOK Center, Consol Energy & Red Rocks Now On Sale 3Health News:Ed Sheeran Tickets at the Hollywood Bowl, Verizon Theatre, The Mann Center, Darlings Waterfront Pavilion, Moda Center, BOK Center, Consol Energy & Red Rocks Now On Sale 4Health News:Burien Nursing and Rehabilitation Center Receives Top Honors with Facility of the Year Award 2Health News:Burien Nursing and Rehabilitation Center Receives Top Honors with Facility of the Year Award 3Health News:RDI-Engineering Participates in STEM”U”LATE Your Mind Event to Host Educational Exhibition 2Health News:Emassagechair Wants Shoppers to Think About the Benefits of Massage During National Sleep Awareness Week 2Health News:Emassagechair Wants Shoppers to Think About the Benefits of Massage During National Sleep Awareness Week 3
... /Xinhua-PRNewswire/ -- Simcere,Pharmaceutical Group (NYSE: SCR ), ... and manufacturer of the patented,anti-cancer biotech product Endu ... Carret & Co.,s Fourth Investor Tour of China,being ... April 4, 2008 in Beijing,Shenzhen and Shanghai., ...
... Beef is Eligible to Carry New Consumer Label, ... for the,implementation of E. coli-safeguards, that include new ... cattle, have been,adopted and implemented by VeriPrime, Inc., ... Beef Technical Advisory Council., (Logo: http://www.newscom.com/cgi-bin/prnh/20080401/AQTU070LOGO ...
... Fork, Care and Prevention, WICHITA, Kan., April ... and higher new safety standards, including protections,against E. ... leading farmers and,ranchers behind the food safety seal, ... Citing growing consumer concern over food safety ...
... 1, 2008 Natural,Nutrition, Inc. (OTC Bulletin Board: ... InterACTIVE Nutrition, Inc. (INII) achieved record unaudited,sales of ... EBITDA for the,year ended December 31, 2007., ... are pleased to,report record results for our first ...
... China,Shenghuo Pharmaceutical Holdings, Inc. (Amex: KUN ) ... the research, development, manufacture,and marketing of pharmaceutical, nutritional ... China ("PRC"), announced its financial,results for full year ... 2007 Highlights -- Net sales totaled ...
... American physicians opinions on health-care financing has found that ... national health insurance while only 32 percent oppose it. ... 2002 found 49 percent of physicians supporting national health ... The 2007 survey results demonstrate a significant change in ...
Cached Medicine News:Health News:Simcere Pharmaceutical Group Announces Participation in Brean Murray Carret & Co.'s Fourth Investor Tour of China 2Health News:VeriPrime Approves New Best Practices for Beef Production 2Health News:VeriPrime Approves New Best Practices for Beef Production 3Health News:'VeriPrime Certified Safeguards' Food Safety Label Unveiled 2Health News:'VeriPrime Certified Safeguards' Food Safety Label Unveiled 3Health News:Natural Nutrition Subsidiary Reports Record Year-End Revenue and EBITDA 2Health News:China Shenghuo Reports Full Year 2007 Financial Results 2Health News:China Shenghuo Reports Full Year 2007 Financial Results 3Health News:China Shenghuo Reports Full Year 2007 Financial Results 4Health News:China Shenghuo Reports Full Year 2007 Financial Results 5Health News:China Shenghuo Reports Full Year 2007 Financial Results 6Health News:China Shenghuo Reports Full Year 2007 Financial Results 7Health News:China Shenghuo Reports Full Year 2007 Financial Results 8Health News:China Shenghuo Reports Full Year 2007 Financial Results 9Health News:China Shenghuo Reports Full Year 2007 Financial Results 10Health News:China Shenghuo Reports Full Year 2007 Financial Results 11Health News:China Shenghuo Reports Full Year 2007 Financial Results 12Health News:China Shenghuo Reports Full Year 2007 Financial Results 13Health News:Indiana University study finds majority of US physicians favor national health insurance 2
Flexible rake retractor, 3 blunt prongs....
Rees bayonet forceps, standard, 5-1/2", TC....
... Implants, designed to accept rigid ... with an excellent reconstructive option ... floor blowout defects. Each design ... of one or more rigid ...
... Medpor Midface Rim is designed ... concavities of the midface, including ... malar. When positioned in the ... Medpor Midface Rim implant aids ...
Medicine Products: